We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The Ministry of Health (MoH) is continuing to work with partners to respond to the Ebola haemorrhagic fever outbreak. As of Wed 8 Aug 2012, the MoH has recorded a total of 23 probable and confirmed cases, including 16 deaths. Of these, 10 cases have been laboratory confirmed by the Uganda Virus Research Institute (UVRI) in Entebbe.
The most recent confirmed case (4 Aug 2012) is being cared for in Kagadi isolation facility. So far, samples from other districts tested have been negative for Ebola. Suspected cases that tested negative during the laboratory investigations have been treated for their ailments and discharged following recovery. All people who came into contact with probable and confirmed cases of Ebola are being followed-up for a period of 21 days. Among the contact persons, 190 have completed 21 days of close monitoring, while 185 are still being closely monitored for any possible sign or symptom of illness.
Advice for Travellers
The European Centre for Disease Prevention and Control (ECDC) has assessed the risk for travellers and EU citizens residing in the country:
"The risk of residents and travellers becoming infected or developing the disease is extremely low, unless there has been direct contact with blood, bodily fluids of dead or living infected persons or animals. As a precautionary measure, EU citizens in Uganda should avoid such contact. Travellers returning from tropical countries should always seek rapid medical attention if they develop flu-like symptoms (such as fever, headache or general malaise) within three weeks after return."
(Via ECDC - accessed 06/08/12)
Advice for Healthcare Professionals
Any patient presenting with a fever (>38ºC) or history of fever in the previous 24 hours, within 21 days of visiting a region where VHFs occur; and who may been exposed to a patient or animal infected with VHF (including their blood, body fluids or tissues); should be assessed as to risk of VHF using the risk assessment algorithm in the Department of Health guidelines.
